Drug Shortage Report for SANDOZ ESOMEPRAZOLE
Report ID | 99066 |
Drug Identification Number | 02460939 |
Brand name | SANDOZ ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-11-11 |
Estimated end date | 2020-08-07 |
Actual end date | 2020-08-03 |
Shortage status | Resolved |
Updated date | 2020-08-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-11-18 | French | Compare |
v1 | 2019-11-18 | English | Compare |